Mavacamten will minimize the level or result of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten might lessen systemic exposures of ethinyl estradiol and progestin, which can bring about contraceptive failure or a rise in breakthrough bleeding. Among https://maximp765cqf2.lotrlegendswiki.com/user